DK1224180T3 - Substituerede azoler - Google Patents

Substituerede azoler

Info

Publication number: DK1224180T3
Authority: DK; Denmark
Prior art keywords: substituted azoles; azoles; substituted
Prior art date: 1999-04-14

Application number

DK00922630T

Other languages

English (en)

Inventor

Achim Schlapbach

Laszlo Revesz

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2000-04-12

Publication date

2003-10-20

1999-04-14 Priority claimed from GBGB9908531.8A external-priority patent/GB9908531D0/en

1999-04-14 Priority claimed from GBGB9908532.6A external-priority patent/GB9908532D0/en

2000-04-12 Application filed by Novartis Ag filed Critical Novartis Ag

2003-10-20 Application granted granted Critical

2003-10-20 Publication of DK1224180T3 publication Critical patent/DK1224180T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK00922630T 1999-04-14 2000-04-12 Substituerede azoler DK1224180T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9908531.8A GB9908531D0 (en)	1999-04-14	1999-04-14	Organic compounds
GBGB9908532.6A GB9908532D0 (en)	1999-04-14	1999-04-14	Organic compounds
PCT/EP2000/003290 WO2000063204A2 (en)	1999-04-14	2000-04-12	Substituted azoles

Publications (1)

Publication Number	Publication Date
DK1224180T3 true DK1224180T3 (da)	2003-10-20

Family

ID=26315413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00922630T DK1224180T3 (da)	1999-04-14	2000-04-12	Substituerede azoler

Country Status (25)

Country	Link
US (1)	US6579874B2 (da)
EP (1)	EP1224180B1 (da)
JP (1)	JP2003503311A (da)
KR (1)	KR20010108504A (da)
CN (1)	CN1378544A (da)
AR (1)	AR023465A1 (da)
AT (1)	ATE244236T1 (da)
AU (1)	AU4295300A (da)
BR (1)	BR0010598A (da)
CA (1)	CA2370417A1 (da)
CO (1)	CO5170501A1 (da)
CZ (1)	CZ20013696A3 (da)
DE (1)	DE60003709T2 (da)
DK (1)	DK1224180T3 (da)
ES (1)	ES2202114T3 (da)
HU (1)	HUP0302747A2 (da)
IL (1)	IL145836A0 (da)
MX (1)	MXPA01010434A (da)
NO (1)	NO20014987L (da)
PE (1)	PE20010031A1 (da)
PL (1)	PL364789A1 (da)
PT (1)	PT1224180E (da)
SK (1)	SK14562001A3 (da)
TR (1)	TR200102967T2 (da)
WO (1)	WO2000063204A2 (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE396978T1 (de)	1999-10-07	2008-06-15	Amgen Inc	Triazin-kinase-hemmer
DE60024480T2 (de)	1999-10-27	2006-07-27	Novartis Ag	Thiazol und imidazo[4,5-b]pyridin verbindungen und ihre verwendung als pharmazeutika
JP2003532635A (ja) *	2000-02-17	2003-11-05	アムジエン・インコーポレーテツド	キナーゼ阻害薬
IL156306A0 (en)	2000-12-21	2004-01-04	Glaxo Group Ltd	Pyrimidineamines as angiogenesis modulators
WO2002051442A1 (en) *	2000-12-26	2002-07-04	Takeda Chemical Industries, Ltd.	Concomitant drugs
EP1364949A4 (en)	2001-02-02	2005-11-23	Takeda Pharmaceutical	JNK INHIBITOR
MXPA03008142A (es)	2001-03-09	2003-12-12	Pfizer Prod Inc	Nuevos compuestos antiinflamatorios de bencimidazol.
OA12552A (en)	2001-03-09	2006-06-06	Pfizer Prod Inc	Triazolopyridines as anti-inflammatory agents.
DE60205974T2 (de)	2001-04-04	2006-06-29	Pfizer Products Inc., Groton	Neue Benzotriazole mit entzündungshemmender Wirkung
CA2450400A1 (en) *	2001-06-11	2002-12-19	Takeda Chemical Industries, Ltd.	Medicinal compositions
TWI231757B (en)	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
KR100903760B1 (ko)	2001-09-21	2009-06-19	솔베이 파마슈티칼스 비. 브이	Ｃｂ1-길항 작용을 가지는 신규한4,5-디하이드로-1ｈ-피라졸 유도체
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
EP1458385A4 (en) *	2001-12-19	2005-12-21	Merck & Co Inc	METABOTROPIC GLUTAMATE RECEPTOR 5-HETEROARYL-SUBSTITUTED IMIDAZOLE MODULATORS
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
ATE349210T1 (de)	2002-07-09	2007-01-15	Boehringer Ingelheim Pharma	Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
US20040132726A1 (en) *	2002-08-09	2004-07-08	Astrazeneca Ab And Nps Pharmaceuticals, Inc.	New compounds
MXPA05001590A (es)	2002-08-09	2005-05-23	Astrazeneca Ab	Compuestos que tienen actividad en los receptores metabotropicos de glutamato.
RU2352568C9 (ru)	2002-08-09	2009-06-27	Астразенека Аб	[1,2,4]оксадиазолы (варианты), способ их получения, фармацевтическая композиция и способ ингибирования активации метаботропных глютаматных рецепторов-5
US7005523B2 (en)	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
PA8579601A1 (es) *	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7037923B2 (en)	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
JP2006508914A (ja) *	2002-08-30	2006-03-16	ファイザー・プロダクツ・インク	トリアゾロ−ピリジン製造のための新規な方法および中間体
US6949652B2 (en)	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
JP2006516548A (ja)	2002-12-30	2006-07-06	アンジオテックインターナショナルアクツィエンゲゼルシャフト	迅速ゲル化ポリマー組成物からの薬物送達法
KR20050096956A (ko)	2003-02-07	2005-10-06	다이이찌 세이야꾸 가부시기가이샤	피라졸 유도체
WO2004072072A1 (en)	2003-02-14	2004-08-26	Pfizer Products Inc.	Triazolo-pyridines as anti-inflammatory compounds
MY143245A (en) *	2004-04-28	2011-04-15	Mitsubishi Tanabe Pharma Corp	4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
US7858800B2 (en)	2004-06-30	2010-12-28	Banyu Pharmaceutical Co., Ltd.	Biaryl derivatives
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1988825B1 (en) *	2006-02-08	2016-12-21	The General Hospital Corporation	Arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
NZ580660A (en) *	2007-04-30	2012-02-24	Abbott Lab	Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US9029411B2 (en)	2008-01-25	2015-05-12	Millennium Pharmaceuticals, Inc.	Thiophenes and uses thereof
EP2108641A1 (en)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
US9090601B2 (en)	2009-01-30	2015-07-28	Millennium Pharmaceuticals, Inc.	Thiazole derivatives
CN102395585A (zh)	2009-01-30	2012-03-28	米伦纽姆医药公司	杂芳基化合物和其作为pi3k抑制剂的用途
US8796314B2 (en)	2009-01-30	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
PE20120325A1 (es) *	2009-05-19	2012-04-12	Dow Agrosciences Llc	Aminopirimidinas sustituidas con arilo como agentes fungicidas
EP2322176A1 (en)	2009-11-11	2011-05-18	Almirall, S.A.	New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
PH12013500274A1 (en)	2010-08-11	2013-03-04	Millennium Pharm Inc	Heteroaryls and uses thereof
US8859768B2 (en)	2010-08-11	2014-10-14	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
WO2012021611A1 (en)	2010-08-11	2012-02-16	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
EP2627181A4 (en)	2010-10-13	2014-03-19	Millennium Pharm Inc	HETEROARYLE AND USES THEREOF
AR086113A1 (es)	2011-04-30	2013-11-20	Abbott Lab	Isoxazolinas como agentes terapeuticos
US20190060286A1 (en)	2016-02-29	2019-02-28	University Of Florida Research Foundation, Incorpo	Chemotherapeutic Methods
WO2018159650A1 (ja) *	2017-02-28	2018-09-07	東レ株式会社	グアニジン誘導体及びその医薬用途
WO2021138391A1 (en)	2019-12-30	2021-07-08	Tyra Biosciences, Inc.	Indazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995013067A1 (en) *	1993-11-08	1995-05-18	Smithkline Beecham Corporation	Oxazoles for treating cytokine mediated diseases
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
EP0863757B1 (en) *	1995-08-10	2003-03-26	Merck & Co., Inc.	2-substituted aryl pyrroles, compositions containing such compounds and methods of use
US6492516B1 (en) *	1999-05-14	2002-12-10	Merck & Co., Inc.	Compounds having cytokine inhibitory activity

2000
- 2000-04-11 CO CO00026470A patent/CO5170501A1/es not_active Application Discontinuation
- 2000-04-12 PE PE2000000337A patent/PE20010031A1/es not_active Application Discontinuation
- 2000-04-12 HU HU0302747A patent/HUP0302747A2/hu unknown
- 2000-04-12 PL PL00364789A patent/PL364789A1/xx not_active Application Discontinuation
- 2000-04-12 TR TR2001/02967T patent/TR200102967T2/xx unknown
- 2000-04-12 DE DE60003709T patent/DE60003709T2/de not_active Expired - Fee Related
- 2000-04-12 JP JP2000612294A patent/JP2003503311A/ja active Pending
- 2000-04-12 CN CN00807552A patent/CN1378544A/zh active Pending
- 2000-04-12 CZ CZ20013696A patent/CZ20013696A3/cs unknown
- 2000-04-12 EP EP00922630A patent/EP1224180B1/en not_active Expired - Lifetime
- 2000-04-12 CA CA002370417A patent/CA2370417A1/en not_active Abandoned
- 2000-04-12 IL IL14583600A patent/IL145836A0/xx unknown
- 2000-04-12 AR ARP000101686A patent/AR023465A1/es unknown
- 2000-04-12 BR BR0010598-8A patent/BR0010598A/pt not_active IP Right Cessation
- 2000-04-12 PT PT00922630T patent/PT1224180E/pt unknown
- 2000-04-12 WO PCT/EP2000/003290 patent/WO2000063204A2/en not_active Ceased
- 2000-04-12 SK SK1456-2001A patent/SK14562001A3/sk unknown
- 2000-04-12 MX MXPA01010434A patent/MXPA01010434A/es unknown
- 2000-04-12 KR KR1020017013086A patent/KR20010108504A/ko not_active Withdrawn
- 2000-04-12 ES ES00922630T patent/ES2202114T3/es not_active Expired - Lifetime
- 2000-04-12 AT AT00922630T patent/ATE244236T1/de not_active IP Right Cessation
- 2000-04-12 DK DK00922630T patent/DK1224180T3/da active
- 2000-04-12 AU AU42953/00A patent/AU4295300A/en not_active Abandoned
2001
- 2001-10-12 US US09/975,913 patent/US6579874B2/en not_active Expired - Fee Related
- 2001-10-12 NO NO20014987A patent/NO20014987L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TR200102967T2 (tr)	2002-01-21
AU4295300A (en)	2000-11-02
NO20014987D0 (no)	2001-10-12
JP2003503311A (ja)	2003-01-28
ES2202114T3 (es)	2004-04-01
US20020049220A1 (en)	2002-04-25
CN1378544A (zh)	2002-11-06
MXPA01010434A (es)	2002-03-27
SK14562001A3 (sk)	2002-03-05
WO2000063204A3 (en)	2002-05-23
CO5170501A1 (es)	2002-06-27
NO20014987L (no)	2001-12-14
HUP0302747A2 (hu)	2003-12-29
PE20010031A1 (es)	2001-02-23
EP1224180B1 (en)	2003-07-02
DE60003709T2 (de)	2004-12-23
PL364789A1 (en)	2004-12-13
ATE244236T1 (de)	2003-07-15
AR023465A1 (es)	2002-09-04
PT1224180E (pt)	2003-11-28
CA2370417A1 (en)	2000-10-26
BR0010598A (pt)	2002-02-05
IL145836A0 (en)	2002-07-25
WO2000063204A2 (en)	2000-10-26
CZ20013696A3 (cs)	2002-02-13
DE60003709D1 (de)	2003-08-07
KR20010108504A (ko)	2001-12-07
US6579874B2 (en)	2003-06-17
EP1224180A2 (en)	2002-07-24

Publication	Publication Date	Title
DK1224180T3 (da)	2003-10-20	Substituerede azoler
NO20016115D0 (no)	2001-12-14	Substituerte heterocykelkondenserte gamma-karboliner
EE200100502A (et)	2002-12-16	Ühendid
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
EE200300049A (et)	2004-10-15	Imidasooli derivaadid
ATA51899A (de)	2002-04-15	Handstempel
DE60018989D1 (de)	2005-04-28	N-carbamoyloxyalkyl-substituierte azolium-verbindungen
ATE360620T1 (de)	2007-05-15	Imidazolderivate
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
DK1070708T3 (da)	2004-05-10	Triazolderivater
NO20013769D0 (no)	2001-08-01	Kalsilytiske forbindelser
NO20020466D0 (no)	2002-01-29	Kalsilytiske forbindelser
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
NO20014262D0 (no)	2001-09-03	Tiazoloindolinon-forbindelser
NO20022927D0 (no)	2002-06-18	Substituerte pyrrazoler
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide
DE10082008D2 (de)	2002-12-19	Ausbeulgerät
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine
ATE251154T1 (de)	2003-10-15	Substituierte phenyluracile
ID29984A (id)	2001-10-25	Senyawa-senyawa bis-stirilbifenil
ATA107599A (de)	2002-06-15	Heizwasserbereiter
DE10085167T1 (de)	2002-11-07	Gangumschalteinrichtung
AT500658A3 (de)	2007-10-15	Isolierplatte
ATA732000A (de)	2004-04-15	Kachelofen
DE10085144T1 (de)	2003-04-24	Polypeptidkomposition